Status:
COMPLETED
Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Sickle Cell Crisis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary goal of this randomized, controlled, open-label study is to determine the efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral intravenous (IVP) catheter pl...
Eligibility Criteria
Inclusion
- Sickle cell patients (all genotypes)
- Patients hospitalized for uncomplicated vaso-occlusive crisis (CVO) in Internal/general Medicine department
- Patients requiring the placement or replacement of a peripheral intra-venous catheter in the Department of Internal/general Medicine
- Patients arrived in the internal/general medicine department of the hospital between 9h and 18h and except weekends
- Signed informed consent.
- Affiliated to the French health care insurance.
Exclusion
- Signs of shock
- Acute chest Syndrome
- Central venous catheter already present
- Indication to have a central venous catheter from the ourset
- Patient who has already participated to the PERFID study during the current hospitalization
- Refusal of the patient's participation
- Pregnant or lactating woman
- Patient under guardianship or curatorship
Key Trial Info
Start Date :
March 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03477552
Start Date
March 30 2018
End Date
May 30 2022
Last Update
January 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU H. Mondor
Créteil, France
2
AP-HP - Hopital Europeen Georges-Pompidou Paris, France
Paris, Île-de-France Region, France, 75908